When was Strand Diagnostics founded?

Strand Diagnostics was founded in 2008 and raised its 1st funding round 4 years after it was founded.

Where is Strand Diagnostics located?

Strand Diagnostics is headquartered in Indianapolis, United States.

How many employees does Strand Diagnostics have?

As of Apr 30, 2026, the latest employee count at Strand Diagnostics is 9.

Is Strand Diagnostics a funded company?

Strand Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Mar 28, 2012.

When was the latest funding round of Strand Diagnostics?

Strand Diagnostics' latest funding was a $***** Series A round on Mar 28, 2012, with participation from 1 investor. Its primary sector is Diversified Diagnostics. Globally, the Diversified Diagnostics sector has seen $20.2M in funding in 2026 to date.

Where does Strand Diagnostics rank among its competitors?

Strand Diagnostics ranks 10th amongst 71 active competitors, of which 6 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was GreenLight Biosciences, which secured $25M in Apr, 2025.

Who are the top competitors of Strand Diagnostics?

Strand Diagnostics' top competitors include GreenLight Biosciences, Veritas Genetics and ARCpoint Labs. Among them, GreenLight Biosciences secured the most recent funding round in April, 2025.

Strand Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Strand Diagnostics is focussed on developing technologies for diagnostics and forensic applications. It developed know error system which utilizes bar coding, forensic principles and DNA matching to confirm that evaluates surgical biopsy samples. It claims that the system is being incorporated in US for the specialties including breast surgeons, radiology, urology, GI, and oncology. The system also provides a DNA Specimen Provenance Assignment or “DSPA” testing to complete the diagnostic testing cycle before initiating treatment.

Key Metrics

Founded Year

2008

Location

Indianapolis, United States

Stage

Series A

Total Funding

$30M in 1 round

Latest Funding Round

Series A, Mar 28, 2012, $*****

Investors

NantWorks & 1 more

Ranked

10^th among 71 active competitors

Employee Count

9 as on Apr 30, 2026

Similar Companies

GreenLight Biosciences & 99 more

View Strand Diagnostics' full profile

Strand Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Strand Diagnostics, LLC. CIN: 352433643 , Belgium, Active		-	-	-

Strand Diagnostics has raised a total funding of $30M over 1 round. Its latest funding round was a Series A round on Mar 28, 2012 for $*****. 1 investor participated in its latest round. Strand Diagnostics has 2 institutional investors.

Here is the list of recent funding rounds of Strand Diagnostics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 28, 2012	3976952	Series A	7066896	7430784	4826835	3477388

Access funding benchmarks and valuations. Sign up today!

View details of Strand Diagnostics's funding rounds and investors

The founders of Strand Diagnostics is Travis Morgan.

Here are the details of Strand Diagnostics' key team members:

Travis Morgan: Former Co-Founder & CFO of Strand Diagnostics.

View details of Strand Diagnostics's Founder profiles and Board Members

Strand Diagnostics' employee count trend

Strand Diagnostics has 9 employees as of Apr 26. Here is Strand Diagnostics's employee count trend over the years:

Employee count trend for Strand Diagnostics

Uncover Strand Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Strand Diagnostics include GreenLight Biosciences, Veritas Genetics and ARCpoint Labs. Here is the list of Top 10 competitors of Strand Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	GreenLight Biosciences 2008, Lexington (United States), Public	Developer of a platform for RNA-based products for life science industry	$225M	Baird Capital, Kodiak Venture Partners & 36 others	69/100
2nd	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	58/100
3rd	ARCpoint Labs 2005, Greenville (United States), Public	Provider of genetic testing services	-	-	55/100
4th	Any Lab Test Now 1992, Alpharetta (United States), Unfunded	Provider of a portfolio of testing services	-	-	50/100
5th	Genotek 2010, Moscow (Russia), Seed	Direct-to-consumer genomic tests	$2.4M	MSU Business Incubator, Rustars Ventures & 1 others	46/100
6th	Kailos 2010, Huntsville (United States), Acquired	Provider of consumer-based genetic testing services	$3.9M	In-Q-Tel, New Capital Partners & 1 others	42/100
7th	Genesis Healthcare 2004, Tokyo (Japan), Series A	Provider of consumer kits and genomic services for researchers	$35.4M	OMRON, Rakuten Capital & 1 others	41/100
8th	Face DNA Test 2018, London (United Kingdom), Unfunded	Provider of diversified DNA testing services	-	-	40/100
9th	Yunhu Technology Group 2017, Hangzhou (China), Series A	Provider of DNA testing services	$38.1M	Cash Capital, 5Y Capital & 5 others	37/100
10th	Strand Diagnostics 2008, Indianapolis (United States), Series A	Assay system and kits for forensics, prostate, breast, bone marrow and other tissue biopsies	$30M	NantWorks, LISC Strategic Investments	37/100